Sea creature-inspired biotech Ascidian surfaces with $50M and a new way to edit RNA

Ascidian Therapeutics is developing therapies for inherited disorders that work by editing RNA, which the startup’s scientists say brings safety and breadth not achievable by currently available genetic medicines.

We Will Reach Longevity Escape Velocity By 2030, According to Experts

Dr Jose Cordeiro, Vice Chair, Humanity Plus, painted an optimistic view on longevity, affirming that cancer has discovered how we stopped aging – we can also discover how we become immortal. He believes people who make it to 2030 will gain one year every year they survive and that “we will have the rejuvenation technology by 2045.”

First-ever cancer vaccine could be ready in months, scientists say

The experimental vaccine is based on mRNA technology that was used to create the Covid vaccines. The cancer shot is tailored for each patient to generate T-cells – a key part of the body’s immune response – based on the specific mutational signature of each tumor.

Nanoengineers Are Using Plant Viruses To Treat Cancer

Nicole Steinmetz and colleagues have received $4.3 million in grants from the National Institutes of Health to advance their research using plant viruses to develop cancer immunotherapies.

The Neuroprotective Effects of Exercise You Need To Know

A recent study found that even small amounts of physical activity can help safeguard against cognitive decline. Scientists understand that it’s plausible that exercise protects the brain from neurodegeneration, but they don’t have proof—nor do they have a clear understanding of how, exactly, it works.

Transplanted livers can keep working for a total of over 100 years

Livers transplanted from older donors can last a century in total and sometimes outlive ones from younger people, according to new research. Now, researchers have provided evidence that transplants from older donors can work very well.

How AI will disrupt the treatment of Parkinson’s

Artificial intelligence (AI) and machine learning (ML) are already having a major impact on the biopharma space, changing the ways in which we develop new therapeutics, identify biomarkers, and treat patients.